Study wrapper · #885
Thermosensitive Hydrogels for Sustained Semaglutide Release: Overcoming Weight Loss Plateau in Diet-Induced Obese Rats.
Wang J, Hu H, Long L, et al. Pharmaceutical development and technology. 2026.
DOI: 10.1080/10837450.2026.2703559PubMed: 42454991
Editor's note
This is a drug-delivery formulation study using a thermosensitive hydrogel to extend semaglutide release in obese rats. Semaglutide is genuinely the subject, but the work is about the delivery system rather than the drug's efficacy, and results are preclinical. Weight for the peptide itself is modest.
Plain-language abstract
Researchers developed a temperature-sensitive gel that slowly releases semaglutide, and in obese rats it produced continuous weight loss over 20 days while improving lipid and liver markers.
Related coverage
Weak / none
A qualitative study exploring experiences about using semaglutide for weight loss in a rural setting in Denmark - 'she is probably on the meds'.
Scandinavian journal of primary health caren=——2026
Mixed
GLP-1 receptor agonists in stroke prevention: a narrative review on emerging therapeutic frontiers.
Annals of medicinen=——2026
Weak / none
Cost-effectiveness of tirzepatide versus semaglutide for patients with obesity or overweight in the US: evidence from the SURMOUNT-5 head-to-head phase-3 trial.
Journal of medical economicsn=——2026